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NEWCOMER to The Rockefeller University
campus on Manhattan's upper East Side
would have some difficulty identifying the
Hospital. Only the decorative use of the ca
duceus on the red brick exterior furnishes a clue. Oth
erwise the Hospital shares the architectural features of
the older buildings on campus, built in the opening dec
ades of this century after the founding of the U �iversity
in 1 go 1 as The Rockefeller Institute for Medical Research.
The Hospital's physical integration into this compact
cluster of buildings is symbolic of its traditionally close
relationship to the institution as a whole, one of the few
in the world today engaged exclusively in scientific re
search and graduate education in the biomedical sciences
and in related behavioral and physical sciences.

A Pioneer in Biomedical Science

The Rockefeller Institute was established by John D.
Rockefeller, Sr., in response to the pressing need for
biomedical research facilities in this country. At that
time, young American physicians bent on scientific ca
reers went to Europe to obtain laboratory training. The
objective of the new institute was to benefit mankind
through basic research and its application to, the under
standing, treatment, and prevention of disease. In carry
ing out that objective, The Rockefeller has been a major
force in bringing the United States to the forefront of
the biological and medical sciences. It has also served as
a model for the establishment of similar research centers.
From its beginnings, scientists have been attracted to the
institution from all parts of the world, and many young
M.D.'s and Ph.D.'s have come here for advanced train
ing. In 1954, the Institute became a graduate university,
and the first Ph.D. degrees were granted in 1959. In
1965, its name was changed to The Rockefeller University.
Compared to general purpose universities, this insti-

tution is modest in size. Its 15-acre campus is the base for
a scientific community of about 1,450 people -250 regular
faculty, 200 postdoctoral fellows and research associates,
1oo graduate students, and a staff of about goo, including
laboratory technicians, nurses, instrument makers, elec
tronics specialists, and other supporting and administra
tive personnel.

A Wide Freedom of Inquiry

The University has an administrative structure built
around more than 50 laboratory groups, a few compris
ing a single scholar and the rest ranging from groups of
3 to more than 35 persons, including students. Although
the laboratory groups represent a great diversity of sci
entific fields, from theoretical physics to behavioral sci
ence, individual investigators are encouraged to cross
disciplinary lines and pursue overlapping interests with
their colleague� in other groups. There are no traditional
departmental boundaries. Rockefeller scientists enjoy a
wide freedom of inquiry and set their own research
goals. Out of this unique organization has come a series
of achievements that, directly or indirectly, have bene
fited the lives of people throughout the world and have
influenced the development of some of the most impor
tant fields in the life sciences.
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HE ROCKEFELLER HOSPITAL has the same

\

rganizational flexibility as have the other Uni
ersity laboratories and, since 1 g 1 o when its
doors were first opened· to patients, it has. op
erated in exactly the same spirit. Rufus Cole, its first
director, insisted that the Hospital should be staffed by
full-time salaried physicians working in their own lab
oratories, but strongly supported by and free to collab
orate with the other institutional laboratories. Cole be
lieved the real purpose of a research hospital was to
attempt to understand the normal physiological char
acteristics of human beings, in order better to analyze
the derangements that occur in disease. In 1910, these
were original concepts: The Rockefeller Hospital was
the first clinical research institution where human dis
ease could be studied and treated in a setting of rigor
ous, scientific inquiry.
This unique approach to clinical research made the
Hospital the pacesetter in revolutionizing academic med
icine in America. Its impact was critically important in
upgrading medical education at a time when many med
ical colleges were no more than trade schools. Most of
the medical school leaders who moved for reform had
served "apprenticeships" in clinical research at The

Rockefeller Hospital. For seven decades, successive gen
erations of clinical researchers have come to the Hospital
for advanced training and have moved on to influential
positions in other institutions.
In the 1950s, the 40-bed Hospital served as an organiza
tional model for the federally supported Clinical Center,
with 500 beds, that was established by the National Insti
tutes of Health in Bethesda, Md., as well as for the
smaller clinical research centers set up, with federal
funding, by more than 80 American medical schools.

Between Medicine and Biology
Infectious and nutritional diseases, which were the pre
dominant lethal or crippling illnesses at the turn of the
century, were a major focus of concern in the creation of
the Hospital. Since then, the Hospital has stood at the
gateway between medicine and biology. The basic, as
well as the clinical, knowledge that has come from the
research at the Hospital has dramatically demonstrated
the importance of the direct study of disease in human
beings.
Often the observation of disease led to a clearer
understanding of life processes; out of this, such new
scientific disciplines as genetics, cell biology, and immu
nology have emerged and reached their present major
status. For example, the nature of bacterial virulence, a
matter of continuing concern to the clinical investigator,
spurred pioneering experiments in biochemical ge
netics, and an important discipline was born. Similarly,
the prevention of infectious disease was the clinical objec
tive that promoted the development of immunology; this
led, in turn, to the discovery of a host of immune-based
disorders. In still another area, the clinical study of pul
monary and kidney failure resulted in the invention of
many basic, now-indispensable tools of biochemistry.
Perhaps the most dramatic example in the Hospital's
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history of how the combination of basic and clinical
research can produce results useful to the practicing
physician and may also result in basic discoveries that
significantly expand our understanding of the mecha
nisms of life is the work of Oswald T. Avery. He and his
gifted associates were investigating the chemistry of the
pneumococcus, causative factor of lobar pneumonia,
when they demonstrated for the first time that DNA is the
genetic material. Their finding, published in 1944, has
been considered the central discovery of twentieth-cen
tury biology.

Focus on Clinical Investigation
Today The Rockefeller University Hospital is the largest
and the only private facility in the country that is devoted
exclusively to clinical investigation. Its staff consists of
about 1o percent of the University's senior faculty mem
bers and their colleagues. The40-bed unitlogs aboutg,ooo
inpatient days each year, as well as an additional 5, ooo
outpatient visits. The patients are drawn not only from
the New York metropolitan area but also from other
states and other countries.
All patients receive the most modern medical care,
without charge, during often lengthy stays for research
on and care of their illnesses. Many patients keep in
touch with the Hospital after their release, either as out
patients or through their own physicians. Like the faculty
of the other University laboratories, faculty members at
the Hospital hold full-time salaried appointments and
do not charge professional or laboratory fees to patients.
Though The Rockefeller Hospital carries out many of
the conventional medical functions of patient care com
mon to.all hospitals-and prides itself on the high quality
of that care-these activities are conducted strictly in the
context of its primary scientific mission.
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UST as the interests of the University have broad
ened and deepened in all branches of the basic life
sciences, so too has the research program of the
Hospital acquired new dimensions. Like their pre
decessors, today's investigators, inspired by the con
cept of human disease as a general biological problem,
are looking ever more deeply into organic structure and
function, while at the same time seeking to integrate
their findings into the "ordered complexity" of animal
physiology and chemistry.
The disorders under study today can be divided into
two broad categori'es-immunology and metabolism. The
largest percentage of bed use in the Hospital is devoted
to research on rheumatoid arthritis, systemic lupus ery
thematosus, and other collagen diseases; problems of
cholesterol metabolism; acute and chronic glomerulo
nephritis; obesity; and diabetes. Dermatologic disorders
and endocrine-related cancer have recently been added
to the list of chronic disabling diseases under study. The
Hospital laboratories also are engaged in research on
rheumatic fever; a variety of genetic disorders, including
the porphyrias; problems of alcoholism, drug addiction,
and nutrition; and clinical pharmacology. A recent and
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growing interest is in the area of biocnemical toxicology
and the impact of environmental chemicals on man.
Investigators in the Hospital frequently join forces
with other scientists on campus on work that demands a
multiplicity of professional skills. In turn, basic research
programs with potential clinical implications draw upon
the resources of the Hospital when appropriate.

Need for Clinical Researchers
In recent years, there has been a declining interest in
clinical research among medical students and graduates
in this country and in most of the western world. If the
trend is not reversed, the growth of medical knowledge
in the next generation will be seriously impaired. A key
step toward the solution of this problem is to provide
assured opportunities and financial support to gifted
young physicians, thus encouraging them to consider
careers in clinical investigation as an alternative to medi
cal practice.
Exposure to outstanding physician-scientists, to a dis
cipline that applies the analytical powers of the modern
sciences to disease problems, and to an atmosphere of
collaborative research between basic scientists and clini
cians is critical to the development of a new generation
of clinical investigators. The Rockefeller Hospital offers
such an environment. It is seeking to recruit outstanding
young physicians who are completing their residency
programs and are prepared to join the Hospital staff in
order to train themselves for careers in the clinical sci
ences.

Th� Right Environment
To a select group of such young men and women, The
Rockefeller Hospital offers full financial support, includ
ing salary and laboratory facilities, for three or more
years. These Clinical Scholars are given faculty appoint-

ments and become full colleagues in the Rockefeller re
search community. Every effort is made to house them
near the campus, situated in one of the most coveted
neighborhoods in New York City.
Young researchers find an unusually rich range of
personal and professional associations open to them
within an institution where almost all of the disciplines
contiguous to medicine are represented. They share in
the intimacy and administrative simplicity that are
among the great strengths of the University and its Hos
pital. They find colleagues willing to open their labora
tories to visitors; to expose their ideas to the scrutiny of
other investigators; to give assistance; and to debate,
persuade, and teach. These associations are further en
hanced by ties, formal and informal, that link the Uni
versity to its immediate neighbors, The New York Hos
pital-Cornell Medical Center and Memorial Sloan
Kettering Cancer Center, as well as to other medical
institutions in New York City. To all this must be added
the best of music, theater, ballet, art, spectator sports,
and recreational facilities of all kinds-virtually at the
doorstep of the University.

Learning by Experience
When Clinical Scholars join a laboratory group at the
Hospital-even if they have had little previous laboratory
experience-they quickly become familiar with the basic
research disciplines of that group. In the first year or so,
they are guided toward a research goal of their own; but
within the very flexible framework of the group they
have considerable freedom of choice. They learn by ex
perience ( since there are no formal courses) to recognize
investigative challenges, to frame important questions,
and to design meaningful experiments and perform the
laboratory work required to answer those questions. At
least 80 percent of their work day is spent in the labora-
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tory. The remainder is devoted to the care of their re
search patients.
This division of time points up the real strength of the
clinical research programs at the Hospital. First, the sci
entists are not burdened by responsibilities for formal
teaching, ward service, or administration. Second, each
investigator can study patients on the metabolic ward for
extended periods without any demand for tightly struc
tured protocols, because it is the tradition at the Hospital
to study small numbers of patients in great detail. Third,
the clinical situation guides the nature of the questions
asked and the manner in which the answers are sought;
the discoveries that result are a measure of the ingenuity
of the investigator. Having demonstrated mastery of the
discipline of patient-oriented research, the trained inves
tigator becomes much sought-after in academic medi
one.

A National Resource
For more than 70 years, the Hospital has served as a na
tional resource in the study of human disease. It has
shown itself capable of adapting effectively to a changing
scientific, academic, and social environment. Its original
purpose not only remains valid but, in fact, is even more
important now as federal funding for clinical research
declines. To ensure against the uncertainties of federal
grants, The Rockefeller University is now engaged in a
ten-year development program to broaden its base of
private financial support. One of the fruits of this effort
is the funding by the University of the Clinical Scholars
program and other major projects designed to strengthen
the Hospital's remarkably productive environment for
discovery.
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Bacteriology and Immunology
This laboratory, headed by Professor Emil C. Gotschlich, has
spent more than three decades in seeking a greater understand
ing of the host's relationship to infectious agents and the diseases
they produce. Among the diseases under study have been those in
which an established relationship to a known microorganism has
been demonstrated as well as those diseases in which a presumed
microbial agent might be involved. In the former category has
been a study of post-streptococcal sequelae as well as group B
infections of the newborn. Knowledge of many of the structures
and functions of hemolytic streptococci has been elucidated. Also,
a genetic marker in rheumatic fever and a nephritogenic protein
unique to nephritis strains have been discovered, and the host's
immune response to microbial infections in these disease states
has been described. Of equal importance has been the elucidation
of the role polysaccharides of the meningococcus play in immu
nity to these infections with the development of active vaccines
against the group A and C meningococcus.
Among the diseases in which a presumed infectious agent may
play a role are rheumatoid arthritis
and multiple sclerosis. In the
'
former, evidence has accrued indicating a possible relationship
between bacterial mucopeptide antigens and the disease state. In
multiple sclerosis, the evidence is inconclusive, but suggests that a
prior viral event coupled with abnormalities in immunoregulation
might trigger a neurological lesion.
Current activities of the laboratory include exploration, in
experimental models and in man, of the relationship of microbial
antigens to rheumatoid arthritis. In rheumatic fever, the role of
the genetic marker in the immune response to streptococcal anti
gens is being explored. In glomerulonephritis particular empha
sis is being placed on the role of a nephritogenic protein in acute
nephritis as well as on pathological mechanisms involved in the
development of chronic glomerulonephritis. Neuroimmunologi
cal studies are conc�ntrated on the role of cellular and humoral
regulatory mechanisms in multiple sclerosis and on a better defi
nition of the role CNS antigens play in chronic neurological dis
eases. Concomitant with these studies of pathogenesis is the con
tinuing basic exploration of bacterial virulence factors important
in the prevention of known infectious diseases.

Biology efAddictive Diseases
The laboratory of Dr. Mary Jeanne Kreek is engaged in the study
of the disposition and physiological effects of addictive agents,
particularly alcohol and narcotics. The goal is to determine fac
tors that contribute to the initiation and perpetuation of addic
tion, and influence treatment.
Current studies focus on the possible roles of chronic liver dis
ease, prevalent in addicted patients, and of altered endocrine and
neuroendocrine function, either drug-induced or spontaneous, in
the occurrence of recidivism following achievement of the drug
free state and in the initial development of addiction. Using vari
ous technologies, this laboratory has made the first documenta
tion of clinically significant interactions between a narcotic and
any other drug, the initial clinical and laboratory discovery of the
effects of chronic opioid administration on enhancing albumin
synthesis, and the first demonstration that the liver acts as a reser
voir for storage and release of long-acting narcotics.
In 1964, P rofessor Vincent P. Dole, Dr. Marie Nyswander, and
Dr. Kreek introduced pharmacological maintenance treatment of
narcotic addiction with methadone, an orally effective, long-act
ing narcotic. Studies conducted at The Rockefeller University
Hospital showed that such treatment prevents narcotic abstinence
and drug-seeking behavior and restores patients to a functional
state. Other studies have shown that chronic methadone treat
ment is medically safe. Studies of the role of ACTH, beta-endor
phin, and other hormones in narcotic abstinence and in drug
seeking behavior of drug-free narcotic addicts and alcoholics are
in progress. Also being explored is the role of endogenous opioids
in the normal physiological control of intestinal motility and in
motility disorders.

Cellular Physiology andlmmun'ology
This laboratory is concerned with the roles of leukocytes and their
products in inflammation, infectious cellular immunity, and
cancer. Headed by Dr. Zanvil A. Cohn, it includes among its fac
ulty Drs. Marcus Horwitz, Carl Nathan, Nadia Nogueira, William
Scott, Samuel Silverstein, Ralph Steinman, and Jay U nkeless. It is
well known for structural and functional analyses of murine
macrophages, their secretory products, and the properties of
their membranes in pinocytosis and phagocytosis. Dendritic cells,
which play essential roles in T-cell stimulation and transplantation
immunity, were first purified in this laboratory.
In the last five years the scope of the laboratory has expanded
to the study of human cells and diseases, opening up opportuni
ties for investigations integrating laboratory and clinical research.
Methods have been developed to purify and culture monocytes
and dendritic cells from human blood and tissues, and to isolate
their plasma membrane proteins and receptors using monoclonal
antibodies. Major disease-related areas under study include:
a) The role of activated macrophages in host defense against
tumors, Legionnaires' disease bacteria, leprosy, and Trypanosoma
cruzi.
b) Tumoricidal and microbicidal properties of reactive oxygen
metabolites (hydrogen peroxide, superoxide anion), and anti
oxidant defenses of normal and malignant cells.
c) Monocyte- and macrophage-derived arachidonic acid me
tabolites (prostaglandins, leukotrienes) in immediate hypersensi
tivity and immune suppression.
d) Biochemistry and functional properties of Fe and comple
ment receptors.
e) Differentiation of mononuclear phagocytes.
f) Production of lymphocyte-activating factors by human den
dritic cells, and the functions of dendritic cells in inflammation
and arthritis.
In conjunction with the appropriate divisions at The New
York Hospital-Cornell Medical Center, this laboratory maintains
Fellowship Training programs leading to Board qualifications in
Infectious Diseases and Hematology-Oncology.

Cutaneous Biology
and Investigative Dermatology
Professor D. Martin Carter, formerly at Yale University, has
established new laboratories at The Rockefeller to explore
fundamental mechanisms operative in disabling skin diseases.
His laboratory group has been studying the relative
contributions of genetic and environmental influences on such
cutaneous functions as aging and skin cancer. The environmental
factors that damage DNA are of special interest, and include photo
injury by ultraviolet irradiation of various wavelengths and by UV
irradiation combined with such phototoxic drugs as psoralens and
chlorpromazine. Proliferative cellular responses have been
characterized in cultured cutaneous fibroblasts exposed to
psoralens and long-wave UV light. The role of pigment as a
defense has been demonstrated in cells and in skin, and
photomediated stimulation by psoralens of pigmentation by way
of tyrosinase activity also has been demonstrated. Further
enhancement of photomediated cellular damage by changes in
temperature and atmospheric oxygen tension are under
investigation. Cytogenetic consequences of photomediated
psoralen�DNA damage have been characterized. Sister chromatid
exchanges (SCEs) have been shown to develop after in vitro
exposure to psoralens and light, and the influences on SCEs of
DNA binding, K m , and DNA-cross-linking potential of various
psoralens have been shown. The capacity of cutaneous cells to
repair psoralen-DNA damage is being studied, using cells from
normal persons and from those who are suspected of having
heritable heightened susceptibility to DNA damage.
This group was among the first to use psoralens and long-wave
UV irradiation to treat patients with psoriasis. By carefully
monitoring psoralen blood levels, it has been possible to modify
photo-treatment times to match maximum skin photosensitivity.
Clearer understanding of psoralen metabolism is the result.

Endocrinology
This laboratory was only recently organized by Professor Jack
Fishman, but the research it is engaged in is a continuation of
work which has been going on for the past 25 years. The focus of
interest is on the biology of the steroid hormones, with particular
emphasis on their role in human physiology and pathophysiology.
The laboratory has pioneered in the characterization of the
biosynthetic and metabolic pathways of the steroidal hormones in
man and has been instrumental in establishing that their
metabolic transformations are not solely catabolic in nature, but
that the biological properties of the metabolites are of major
consequence in the expression of hormone action. In the course
of these studies, entire new categories of natural steroids have
been identified, among them the catechol estrogens and the
cortoic acids. The former are now known to exhibit unique central
properties and are under intensive examination for their role in
the control of pituitary hormone release in the human. The
differential biological properties of steroid metabolites give
emphasis to the changes in their formation that are associated
with certain diseases. The existence of specific and distinct
perturbations of steroid hormone metabolism have now been
documented in several diseases.
Investigations are also concerned with the impact of diet,
drugs, and other environmental agents on hormone
biotransformation in man, in the expectation that changes in the
latter are responsible for some of the physiological effects of these
factors. The role of estrogen metabolism in human reproduction
and its involvement in the etiology of breast and endometrial
cancer are also u�der intensive study.
The clinical investigations have their counterpart in laboratory
studies directed at the biochemical mechanisms of hormone
biosynthesis and transformation, and at the nature of their
biological action in appropriate target tissues, including the
central nervous system.

Human Behavior and Metabolism
The laboratory of Professor Jules Hirsch and colleagues utilizes
the findings of behavioral science, metabolism, and endocrinology
to understand the nature of human obesity and the manner in
which man and animals control food intake and energy
metabolism. This laboratory has pioneered in the demonstration
that obese subjects, even after reducing their weight, show
persistent abnormalities in adipose cellularity, with an excess
number of small adipocytes when compared to nonobese subjects.
The reduced obese also show behavioral abnormalities which
resemble those described in starvation. Studies now in progress
utilize subjects in the Rockefeller Hospital and in its outpatient
departments, as well as a variety of animal models of obesity
maintained in the Laboratory Animal Research Center at The
Rockefeller University.
Present areas of investigation include:
a. Taste in three-day-old infants. The development of sweet
taste in man and its relationship to food intake and body size.
b. Adipose tissue metabolism, studied in vitro with adipose
tissue aspirates. The effect of cell size on sensitivity to lipolytic
agents.
c. Changes in hypothalamic-pituitary function as a result of
weight loss. Measures of TSH and ACTH, as well as insulin,
growth hormone, and cholecystokinin, in man and experimental
animals.
d. The effect of lipectomy, high caloric intake, and early
infantile feeding on the cellularity and behavior of obese and
normal rodents.
Studies currently beginning are the effect of diet and adipose
tissue composition on serum lipid level and on immune function,
and the �ffect of weight reduction in man on thermogenesis and
autonomic function.

Lipid and Lipoprotein Metabolism.
This laboratory, initiated in 1952 by Professor Edward H. Ahrens,
Jr., has engaged in studies of lipid and lipoprotein metabolism in
man: effects of various dietary fats on plasma lipid and
lipoprotein levels, milk fat composition, erythrocyte lipids, and
adipose tissue composition; effects of carbohydrate/fat exchanges
on plasma lipids; absorption of fat by the intestine; mechanistic
studies of lipid-lowering drugs. These studies depended on the
development and refinement of new methods for use with
patients as well as in the laboratory, including the first application
of gas-liquid chromatography in this country; the measurement of
intestinal lengths under physiological conditions; the sampling of
adipose tissue by needle aspiration; the measurement of biliary
lipid flow rates; and the introduction of orally fed liquid formulas
for research.
For the last 15 years, this group has focused on sterol
metabolism in man. By developing and refining the sterol balance
technique and by combining it with studies of isotope kinetics, it
has become possible to measure the key regulatory factors
governing the movement of cholesterol in, through, and out of
the body, and thus to understand the mode of action of dietary
and drug interventions aimed at reducing plasma and tissue lipid
levels. These studies have demonstrated that individual patients
respond very differently to diet/drug challenges. Present efforts of
the laboratory are directed mainly to measuring the precision of
feedback control of cholesterol synthesis in large numbers of
outpatients, in order to tailor the management of hyperlipidemia
to the pathogenetic defects in each person.
The laboratory also is engaged in studies of cholesterol
synthesis in mononuclear cells and in the intestinal mucosa; in
defining the kinetics of mevalonate metabolism in man and in
laboratory animals; in studies of sterol metabolism in patients
maintained solely by total parenteral nutrition; and in a wide
variety of functional studies of changes in membrane fluidity
effected by the feeding of saturated and polyunsaturated fats.

Medical Biochemistry
The objective of this laboratory, established in 1971 by Professor
Anthony Cerami, is to apply the knowledge of chemistry to
understand the pathogenesis of diseases and to develop drugs to
treat them. The major areas of research are diabetes and aging,
parasitology, and genetic diseases.
The purpose of the diabetes research is to ensure understand
ing of the biochemical mechanism of the disease's many sequelae
and to develop ways to prevent these complications. Studies on
the biochemical basis of the sequelae have led to the concept that
glucose can chemically react with body proteins in a nonenzymatic
manner, and that the higher the glucose concentration, the
greater the reaction. As a result of these findings, the degree of
carbohydrate control can be monitored in diabetic patients. This is
accomplished by assessing the amount of sugar-hemoglobin com
ponent (hemoglobinA 1 J, which in turn gives a measure of the
previous month's integrated blood glucose concentration. A
method of measuring glyco-peptides found in urine has been
developed. As a result of studies on nonenzymatic reactions, the
concept of a delivery system capable of supplying insulin to the
body as a function of glucose concentration was developed, and a
practical apparatus is in progress.
Significant work has been done on cataract formation and
peripheral neuropathy, the two major complications associated
with diabetes, and an increased amount of reaction of glucose with
important proteins in both the lens and peripheral nerve has been
found.
New drugs have been found for the parasitic diseases trypano
somiasis, leishmaniasis, and filariasis. An in-depth study of host
to-parasite response is of prime importance in understanding the
basic disease processes.
Pharmacological agents for treating genetic diseases have been
emphasized in this laboratory. New agents for sickle-cell anemia,
thalassemia, and cystic fibrosis are now being evaluated.

Metabolism-Pharmacology
The laboratory of Professor Attallah Kappas focuses on
biochemical and clinical problems involving the oxygen-binding
pigment heme; the pathways by which it is synthesized and
degraded; and the various roles which heme plays in cellular
metabolism and the biotransformation of such natural and foreign
chemicals as hormones, drugs, and environmental pollutants.
The main diseases under intensive investigation are the
human porphyrias, which, in one form or another, result from
genetic aberrations in activities of the various enzymes in
porphyrin and heme production. Certain acquired disorders of
heme metabolism, such as metal poisoning, and some drug
intoxications are also being studied. The general approach is to
examine- at the biochemical level and in a number of
tissue-culture or animal-model systems- the factors that regulate
heme and heme-protein (cytochrome P450) metabolism, and to
translate the findings of such studies to the human situation when
that is feasible and useful.
Laboratory investigations relevant to the main interests of the
group include the manner in which metals regulate the
degradation of heme in tissue-cultured liver cells and in the
organs of whole animals; the adaptations which take place in vivo
to protect against the detrimental effects of environmental
chemicals, especially trace and heavy metals; means for
controlling the activity of heme-pathway enzymes in order to
achieve selective biological effects involving heme synthesis or
· degradation; and the development of sensitive analytical methods
for analysis of all products and intermediates of the heme
pathway. Thus, application of these methods to diagnostic use in
humans can be achieved, utilizing the smallest possible biological
samples.
A newly developing interest of the laboratory group is the role
of nutritional factors in regulating drug, hormone, and other
chemical biotransformations.
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